Mitchell H. Finer, Chief Scientific Officer at bluebird bio, Inc. (BLUE), sold 15,000 shares at $188.59 ($2.9M) on 2015-06-01, disclosed to the SEC on 2015-06-03.
Scheduled sale ($2.9M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $188.59 | 4,842 | $913K | 32.0% |
| 2 | $189.25 | 1,593 | $301K | 10.6% |
| 3 | $190.57 | 3,106 | $592K | 20.7% |
| 4 | $191.42 | 4,022 | $770K | 27.0% |
| 5 | $192.36 | 813 | $156K | 5.5% |
| 6 | $193.31 | 375 |
| $72K |
| 2.5% |
| 7 | $194.35 | 83 | $16K | 0.6% |
| 8 | $195.07 | 166 | $32K | 1.1% |
| Total | $190.25 avg | 15,000 | $2.9M | 100% |
| Filing → |
| BLUE | SELL | 2015-05-06 | $2.0M | — | Filing → |
| BLUE | SELL | 2015-04-22 | $1.9M | — | Filing → |
| BLUE | SELL | 2015-04-08 | $1.8M | — | Filing → |